Psychobiotics in Depression: Sources, Metabolites, and Treatment—A Systematic Review
Nutrients · 2025
DOI: 10.3390/nu17132139 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2025. Verfasst von Angelika Śliwka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Microbiology and Human Nutrition, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skro…. Hauptthemen laut MEDLINE: Probiotics, Depression. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Depression and other stress-related mental disorders are the leading causes of disability worldwide, making them a significant global health challenge. This systematic review aimed to determine the effects of psychobiotic microorganisms on mental health outcomes, with particular focus on their sources, metabolites, and therapeutic potential for depression.
Methods
A systematic review following PRISMA guidelines was conducted using publications from 2020 to 2024 in Web of Science, Scopus, and PubMed databases. Inclusion criteria encompassed studies examining psychobiotics and their effects on mental health in humans and experimental animals. Risk of bias assessment was performed using the Cochrane Risk of Bias Tool (ROB 2).
Results
Of 369 identified articles, 45 met inclusion criteria. The predominant psychobiotic strains belonged to Lactobacillus (45.5%) and Bifidobacterium (29%) genera. Strain sources included commercial preparations (24%), human-derived (16%), and food-derived (16%) strains. Psychobiotic bacterial strains produce neuromodulatory metabolites, such as short-chain fatty acids (SCFAs), neurotransmitters (e.g., GABA and serotonin), and indole derivatives that influence the gut–brain axis. Their mechanisms of action include neurotransmitter regulation (27.1%), modulation of the gut microbiota (27.1%), SCFA production (16.9%), and control of inflammatory responses (15.3%). Lactobacillus plantarum, Bifidobacterium breve, and Akkermansia muciniphila demonstrated particularly promising effects.
Conclusions
Psychobiotics show significant potential as adjunctive and therapeutic agents in depressive disorders through modulation of the gut–brain axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Microbiology and Human Nutrition, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704 Lublin, Poland.
- Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland.
ORCID-Profile: Angelika Śliwka, Magdalena Polak-Berecka, Kinga Zdybel, Agnieszka Zelek-Molik, Adam Waśko
Zitieren
APA
Śliwka, A., Polak-Berecka, M., Zdybel, K., Zelek-Molik, A., & Waśko, A. (2025). Psychobiotics in Depression: Sources, Metabolites, and Treatment—A Systematic Review. Nutrients. https://doi.org/10.3390/nu17132139
Vancouver
Śliwka A, Polak-Berecka M, Zdybel K, Zelek-Molik A, Waśko A. Psychobiotics in Depression: Sources, Metabolites, and Treatment—A Systematic Review. Nutrients. 2025. doi:10.3390/nu17132139
BibTeX
@article{liwka2025,
author = {Śliwka, Angelika and Polak-Berecka, Magdalena and Zdybel, Kinga and Zelek-Molik, Agnieszka and Waśko, Adam},
title = {Psychobiotics in Depression: Sources, Metabolites, and Treatment—A Systematic Review},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17132139}
}
EUVIMED